Djm. Delsing et al., Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice, CIRCULATION, 103(13), 2001, pp. 1778-1786
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-The present study investigated whether the ACAT inhibitor avasim
ibe can reduce atherogenesis independently of its cholesterol-lowering effe
ct in ApoE*3-Leiden mice.
Methods and Results-Two groups of 15 female ApoE*3-Leiden mice were put on
a high-cholesterol (PIC) diet; 1 group received 0.01% (wt/wt) avasimibe mix
ed into the diet. The HC diet resulted in a plasma cholesterol concentratio
n of 18.7 +/-2.6 mmol/L. Addition of avasimibe lowered plasma cholesterol b
y 56% to 8.1 +/-1.2 mmol/L, caused mainly by a reduction of and composition
change in VLDL and LDL. In a separate low-cholesterol (LC) control group,
plasma cholesterol was titrated to a level comparable to that of the avasim
ibe group (10.3 +/-1.3 mmol/L) by lowering the amount of dietary cholestero
l. After 22 weeks of intervention, atherosclerosis in the aortic root area
was quantified. Treatment with avasimibe resulted in a 92% reduction of les
ion area compared with the HC control group. Compared with the LC control,
avasimibe reduced lesion area by 78%. After correction for the slight diffe
rence in cholesterol exposure between the LC control and avasimibe groups,
the effect of avasimibe on lesion area (73% reduction) remained highly sign
ificant. In addition, monocyte adherence to the endothelium, free cholester
ol accumulation, and lesion severity were reduced by avasimibe treatment.
Conclusions-Treatment with avasimibe potently lowered plasma cholesterol le
vels in ApoE*3-Leiden mice and considerably reduced atherosclerotic lesion
area in addition to its cholesterol-lowering effect. Because monocyte adher
ence to the endothelium and lesion severity were also reduced by avasimibe,
treatment with avasimibe may result in higher plaque stability and therefo
re a reduced risk of plaque rupture.